TickerFacts.

Compare

Acadia Pharmaceuticals Inc vs Prestige Consumer Healthcare Inc. vs Madrigal Pharmaceuticals, Inc. vs Ionis Pharmaceuticals Inc

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearAcadia Pharmaceuticals Inc
ACAD		Prestige Consumer Healthcare Inc.
PBH		Madrigal Pharmaceuticals, Inc.
MDGL		Ionis Pharmaceuticals Inc
IONS
Year ended2025-12-312026-03-312025-12-312025-12-31
Revenue$1.07B$1.09B$958.40M$943.71M
Revenue growth (YoY)+11.9%-4.3%+432.1%+33.8%
Gross margin91.7% (computed)54.7%n/an/a
Operating margin9.8%28.4%-31.3%-40.4%
Net margin36.5%17.5%-30.1%-40.4%
Net income$391.00M$190.30M-$288.28M-$381.39M
EPS (Diluted)$2.30$3.91-$12.85-$2.38
Operating cash flow$109.84M$257.63M-$189.55M-$268.58M
Free cash flow$105.15M$246.45M-$190.02M-$320.03M
Cash & equivalents$177.69M$63.87M$198.69M$372.26M
Total assets$1.56B$3.49B$1.26B$3.52B
Total liabilities$336.81M$1.61B$656.90M$3.03B
Shareholders' equity$1.23B$1.89B$602.69M$489.09M
Return on year-end equity31.9%10.1%-47.8%-78.0%
Shares outstanding170.31Mn/a22.84M163.30M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearAcadia Pharmaceuticals IncPrestige Consumer Healthcare Inc.Madrigal Pharmaceuticals, Inc.Ionis Pharmaceuticals Inc
Latest$1.07B
Ended 2025-12-31		$1.09B
Ended 2026-03-31		$958.40M
Ended 2025-12-31		$943.71M
Ended 2025-12-31
1 year earlier$957.80M
Ended 2024-12-31		$1.14B
Ended 2025-03-31		$180.13M
Ended 2024-12-31		$705.14M
Ended 2024-12-31
2 years earlier$726.44M
Ended 2023-12-31		$1.13B
Ended 2024-03-31		$0
Ended 2023-12-31		$787.65M
Ended 2023-12-31
3 years earlier$517.24M
Ended 2022-12-31		$1.13B
Ended 2023-03-31		$0
Ended 2022-12-31		$587.37M
Ended 2022-12-31
4 years earlier$484.14M
Ended 2021-12-31		$1.09B
Ended 2022-03-31		$0
Ended 2021-12-31		$810.46M
Ended 2021-12-31